In a head-to-head comparison trial pitting ALCAR against carnitine, only ALCAR reduced several biomarkers of oxidative stress within the brain, including those for lipid peroxidation, DNA oxidation, and protein oxidation [21]
This study was supported by The Project Promoting The Research and Development (R&D) Center on Regenerative Medicine in Yamaguchi Prefecture
Multidistrict Litigation 3094 MDL 3094 refers to a multi-district litigation case consolidated in the Eastern District of Pennsylvania Federal Court against drug manufacturers Novo Nordisk (Ozempic, Wegovy, and Rybelsus) and Eli Lilly and Company (Trulicity and Mounjaro)
What This Could Mean for Patients If future studies confirm these effects, people living with both asthma and type 2 diabetes or obesity may see new options for managing their conditions
The first multicentre, prospective, double-blind, placebo-controlled study to assess the usefulness of acetyl-l-carnitine in peripheral neuropathy was conducted by De Grandis et al